The overall purpose of the Genomics/Endocrine/Statistics Core is to provide a common set of state-of-the-art biochemical and genetic analyses as well as statistical support to NCDDG researchers. The laboratories of the Core will provide assessments of hypothalamic-pituitary-adrenal axis and endocrine function, detailed genetic analyses and statistical support to the individual research projects of the NCDDG. Having these determinations performed by a central facility using a common set of assay modalities, common databases and statistical expertise will provide consistency across the 5 projects included in this 5 year study. Additionally, having a Core devoted to these analyses will guarantee high quality assay performance, allow for economies-of-scale in the purchase of assay reagents and technician time, and enable NCDDG investigators to more fully concentrate their efforts on the unique aspects of their particular project.
Mood and anxiety disorders are the most common of all psychiatric disorders and are associated with very significant morbidity and mortality. The primary goal of NCDDG Center is to accelerate the development of novel drugs for the treatment of depression and anxiety. The Genomics/Endocrine/Statistics Core will provide a common set of state-of-the-art biochemical and genetic analyses as well as statistical support to NCDDG researchers.
|Kilts, Clint D; Kennedy, Ashley; Elton, Amanda L et al. (2014) Individual differences in attentional bias associated with cocaine dependence are related to varying engagement of neural processing networks. Neuropsychopharmacology 39:1135-47|
|Kaye, Joanna L; Dunlop, Boadie W; Iosifescu, Dan V et al. (2014) Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: examining the convergence of performance-based measures and self-reports. J Psychiatr Res 57:51-7|
|Dunlop, Boadie W; Rothbaum, Barbara O; Binder, Elisabeth B et al. (2014) Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial. Trials 15:240|
|Sink, K S; Chung, A; Ressler, K J et al. (2013) Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors. Behav Brain Res 243:286-93|
|Zoellner, Lori A; Rothbaum, Barbara O; Feeny, Norah C (2011) PTSD not an anxiety disorder? DSM committee proposal turns back the hands of time. Depress Anxiety 28:853-6|
|Sink, Kelly S; Walker, David L; Yang, Yong et al. (2011) Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J Neurosci 31:1802-10|
|Mathew, Sanjay J; Vythilingam, Meena; Murrough, James W et al. (2011) A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur Neuropsychopharmacol 21:221-9|
|Martin, Elizabeth I; Ressler, Kerry J; Binder, Elisabeth et al. (2010) The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin Lab Med 30:865-91|
|Binder, E B; Nemeroff, C B (2010) The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 15:574-88|
|Martin, Elizabeth I; Ressler, Kerry J; Jasnow, Aaron M et al. (2010) A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol Psychiatry 67:1212-6|
Showing the most recent 10 out of 35 publications